MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-17-0014257
Ananjay Pharmaceuticals Private Limited
Ananjay Pharmaceuticals Private Limited - pharma in Bhopal, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.18 Cr
▲ 61% YoY
Net loss · FY 2025
₹3.15 Cr
Net margin -34.3%
EBITDA · FY 2025
-₹1.83 Cr
EBITDA margin -19.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Satisfied charges
₹10.91 Cr
No open charges
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About Ananjay Pharmaceuticals Private Limited
Data last updated:
Ananjay Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2014PTC033507. Its GSTIN is 23AAOCA3123H1Z0 (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Anupam Chouksey and Dharmendra Shivhare Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No – 31 Shyamla Road Shyamla Hills, Bhopal, Madhya Pradesh, India – 462001.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.18 Cr, a growth of 61% compared to the previous year. For the same year it recorded a net loss of ₹3.15 Cr (net margin -34.3%) and EBITDA of -₹1.83 Cr (EBITDA margin -19.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 32% over five years.
Its group structure includes 1 subsidiary.
As per MCA filings, the company has satisfied charges of ₹10.91 Cr on record.
Ananjay Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-17-0014257). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232MP2014PTC033507
Registration Number 033507
Incorporation Date 02 December 2014
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-17-0014257
Recognitions & Rankings of Ananjay Pharmaceuticals
Contact details
Ananjay Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressH No – 31 Shyamla Road Shyamla Hills, Bhopal, Madhya Pradesh, India – 462001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ananjay Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Ananjay Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ananjay Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ananjay Pharmaceuticals Private Limited, buy the company report.
Financials of Ananjay Pharmaceuticals Private Limited
FY 2025 filings availableAnanjay Pharmaceuticals Private Limited reported revenue of ₹9.18 Cr (up 61% YoY) for FY 2025.
Revenue · FY 2025
₹9.18 Cr ▲ 61%
Net loss · FY 2025
₹3.15 Cr margin -34.3%
EBITDA · FY 2025
-₹1.83 Cr margin -19.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 61%
3 years · compounded
▼ 2%
5 years · compounded
▲ 32%
EBITDA CAGR growth
3 years · compounded
▼ 53%
5 years · compounded
▼ 56%
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 61% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.83 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.15 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -19.9% | ||||
| Net Profit Margin | -34.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ananjay Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ananjay Pharmaceuticals Private Limited
Ananjay Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anupam Chouksey Also directs: LN International Studies LLP, Parvati Sweetners and Power Limited, Ramlala Food Industries Private Limited and 5 more | Director | 02 Dec 2014 | 11 Years 10 Months | Current |
| Dharmendra Shivhare Kumar | Director | 28 Jan 2019 | 7 Years 8 Months | Current |
Peer comparison
Ananjay Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gloss Pharmaceuticals Private Limited | ₹9.22 Cr (FY 2025) | -2.0% | Uttar Pradesh, India | |||
| Elegant Chemical Enterprises Pvt Ltd | ₹9.21 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Tamman Titoe Pharma Private Limited | ₹9.2 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Ananjay Pharmaceuticals Private Limitedthis company | ₹9.18 Cr (FY 2025) | -₹3.15 Cr | -34.3% | 61.0% | Bhopal, Madhya Pradesh, India | |
| Jandj Dechane Laboratories Pvt Ltd | ₹9.15 Cr (FY 2025) | -5.0% | Telangana, India | |||
| Dermocare Laboratories(Gujarat) Private Limited | ₹9.12 Cr (FY 2017) | -2.0% | Changodar, Gujarat, India | |||
| Manara Healthcare Private Limited | ₹9.1 Cr (FY 2025) | 48.0% | Aroor, Kerala, India |
To see the full peer comparison of Ananjay Pharmaceuticals Private Limited, buy the company report.
Auditor
Ananjay Pharmaceuticals Private Limited is audited by SANGHVI MALVIYA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANGHVI MALVIYA & CO | FY 2023 | 001884C |
Shareholding
The shareholding of Ananjay Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ananjay Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹10.91 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Feb 2021 | 100422316 | Others | ₹1.16 Cr | Satisfied | |
| 09 Apr 2019 | 100254743 | Others | ₹9.75 Cr | Satisfied |
To see the full charge records of Ananjay Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Ananjay Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ananjay Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Ananjay Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Vitamax Healthcare Private Limited | U24230MP2008PTC020939 |
To see the full group structure of Ananjay Pharmaceuticals Private Limited, buy the company report.
GST
Ananjay Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAOCA3123H1Z0 | Madhya Pradesh | Active | 06 Jul 2017 |
To see the full GST registrations and return filing status of Ananjay Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ananjay Pharmaceuticals Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Dharmendra Shivhare Kumar ceased to be Additional Director on 30 Sep 2019.
AGM
Ananjay Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ananjay Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge registered on 16 Feb 2021 via Charge ID 100422316 with Others was fully satisfied on 28 Jun 2023.
Charges
A charge registered on 09 Apr 2019 via Charge ID 100254743 with Others was fully satisfied on 28 Jun 2023.
Charges
A charge with Others amounted to Rs. 115.57 Lakh with Charge ID 100422316 was registered on 16 Feb 2021.
Charges
A charge with Others of Rs. 975.00 Lakh registered on 09 Apr 2019 with Charge ID 100254743 was modified on 06 Feb 2020.
Ceased
Dharmendra Shivhare Kumar ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 975.00 Lakh with Charge ID 100254743 was registered on 09 Apr 2019.
Appointed
Dharmendra Shivhare Kumar was appointed as Director.
Ceased
Virat Jaiswal ceased to be Director.
Appointed
Anupam Chouksey was appointed as Director.
Incorporation
02 Dec 2014
Ananjay Pharmaceuticals Private Limited was registered on 02 Dec 2014 with Roc Gwalior & aged 11 years 10 months as per MCA records.
Frequently asked questions
Ananjay Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 December 2014 (12+ years old) and is registered under CIN U24232MP2014PTC033507.
Ananjay Pharmaceuticals has 2 current directors:
- Anupam Chouksey - Director
- Dharmendra Shivhare Kumar - Director
The latest financial statements of Ananjay Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ananjay Pharmaceuticals is 23AAOCA3123H1Z0, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Ananjay Pharmaceuticals is U24232MP2014PTC033507. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ananjay Pharmaceuticals was incorporated on 02 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Ananjay Pharmaceuticals by revenue are Gloss Pharmaceuticals Private Limited, Elegant Chemical Enterprises Pvt Ltd, Tamman Titoe Pharma Private Limited, Jandj Dechane Laboratories Pvt Ltd, Dermocare Laboratories(Gujarat) Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dharmendra Shivhare Kumar ceased to be Additional Director on 30 Sep 2019. Dharmendra Shivhare Kumar was appointed as Director on 28 Jan 2019. Virat Jaiswal ceased to be Director on 28 Jan 2019. Ananjay Pharmaceuticals has 4 board changes on record in total.
Yes, Ananjay Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-17-0014257).
The registered office of Ananjay Pharmaceuticals is at H No – 31 Shyamla Road Shyamla Hills, Bhopal, Madhya Pradesh, India – 462001.
Ananjay Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.